|
KMID : 1141720150030010001
|
|
폐쇄성폐질환
2015 Volume.3 No. 1 p.1 ~ p.1
|
|
|
|
|
Kim Hyun-Chul
|
|
|
Abstract
|
|
|
The level of R&D spending (Research & Development) by Ministry of Health and Welfare, based on Health and Medical Technology Promotion Act, started at KRW 20.3B in 1995 and grew over a period of 20 years to reach KRW 461.5 in 2014. In this study, we discuss the legal basis of R&D spending by Ministry of Health and Welfare, its governance, financial status, basic plans, and current project statuses. We then review the details of R&D support for the Ministry of Health and Welfare for obstructive pulmonary diseases at 2013, and provide a forecast for R&D support in 2015. While 70% of R&D spending at Ministry of Health and Welfare is based on Health and Medical Technology Promotion Act, the remainder is also based on numerous other laws including the Cancer Control Act. As for the governance of R&D support at the Ministry of Health and Welfare, the Heath Technology Policy Review Committee is established as the highest reviewing body, overseeing numerous departments and institutions within the ministry such as Division of Healthcare Technology Development. The source of research cost includes general account budget, special account budget, and National Health Promotion Fund,
however, the National Health Promotion Fund has experienced slowdown recently due to issues in consistency with the stated purpose for establishing the fund. As for the R&D master plan at Ministry of Health and Welfare, which is the Master plan for Health Technology Research and Development, an expanded concept of R&D for health covering prevention and management (previously focused on the treatment only) has been defined to establish the basic plan. Among the R&D support projects in 2014 from the ministry of Health and Welfare, the projects that can provide support for research costs for obstructive pulmonary diseases appear mainly to be Research & Development for Overcoming Diseases Project and High-tech Biomedical Research & Development Project. As of 2013, investment in obstructive pulmonary diseases is estimated to be KRW 4,778 million (19 projects), including support from the following: Research & Development for Overcoming Diseases Project (KRW 2,208 million, 13 projects); High-tech Biomedical Research & Development Project (KRW 1,770 million, 5 projects), and Advanced Technology Development for Traditional Korean Medicine Project (KRW 200 million, 1 project). In 2015, additional support is expected to be available for new projects from Generic Technology Development for Converging of Western and Traditional Korean Medicine Project as well as Advanced Technology Development for Traditional Korean Medicine Project. Further, National Health Promotion Fund will be promoted through increased tax on cigarettes after reform in the National Health Promotion Law. R&D spending from National Health
Promotion Fund is expected to be spent on the smoking-related issues and deserves further attention.
|
|
|
KEYWORD
|
|
|
Financing, Government, Biomedical research
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|